PTP Accounts Production v23.1.5.20 SC648825 director 1.1.23 31.12.23 31.12.23 Property management false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC6488252022-12-31SC6488252023-12-31SC6488252023-01-012023-12-31SC6488252021-12-31SC6488252022-01-012022-12-31SC6488252022-12-31SC648825ns15:Scotland2023-01-012023-12-31SC648825ns14:PoundSterling2023-01-012023-12-31SC648825ns10:Director12023-01-012023-12-31SC648825ns10:PrivateLimitedCompanyLtd2023-01-012023-12-31SC648825ns10:SmallEntities2023-01-012023-12-31SC648825ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-31SC648825ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-31SC648825ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-31SC648825ns10:FullAccounts2023-01-012023-12-31SC648825ns10:RegisteredOffice2023-01-012023-12-31SC648825ns5:CurrentFinancialInstruments2023-12-31SC648825ns5:CurrentFinancialInstruments2022-12-31SC648825ns5:ShareCapital2023-12-31SC648825ns5:ShareCapital2022-12-31SC648825ns5:RetainedEarningsAccumulatedLosses2023-12-31SC648825ns5:RetainedEarningsAccumulatedLosses2022-12-31SC648825ns5:OwnedAssets2023-01-012023-12-31SC648825ns5:OwnedAssets2022-01-012022-12-31SC648825ns5:PlantMachinery2022-12-31SC648825ns5:PlantMachinery2023-01-012023-12-31SC648825ns5:PlantMachinery2023-12-31SC648825ns5:PlantMachinery2022-12-31
REGISTERED NUMBER: SC648825 (Scotland)















Report of the Director and

Unaudited Financial Statements for the Year Ended 31 December 2023

for

MYCOSY PARTNERS LTD

MYCOSY PARTNERS LTD (Registered number: SC648825)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Report of the Director 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 5


MYCOSY PARTNERS LTD

Company Information
for the Year Ended 31 December 2023







DIRECTOR: M Garcia





REGISTERED OFFICE: The Kriek
Mill of Uras
Stonehaven
Aberdeenshire
AB39 2TQ





REGISTERED NUMBER: SC648825 (Scotland)





ACCOUNTANTS: MacDonald Accountancy Services
11 Margaret Street
Stonehaven
Aberdeenshire
AB39 2AY

MYCOSY PARTNERS LTD (Registered number: SC648825)

Report of the Director
for the Year Ended 31 December 2023

The director presents her report with the financial statements of the company for the year ended 31 December 2023.

DIRECTOR
M Garcia held office during the whole of the period from 1 January 2023 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





M Garcia - Director


23 September 2024

MYCOSY PARTNERS LTD (Registered number: SC648825)

Income Statement
for the Year Ended 31 December 2023

31.12.23 31.12.22
Notes £    £   

TURNOVER 37,801 34,098

Administrative expenses 17,989 18,482
OPERATING PROFIT and
PROFIT BEFORE TAXATION 19,812 15,616

Tax on profit 4,163 3,367
PROFIT FOR THE FINANCIAL YEAR 15,649 12,249

MYCOSY PARTNERS LTD (Registered number: SC648825)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 - 2,100

CURRENT ASSETS
Cash at bank 49,989 131,547

CREDITORS
Amounts falling due within one year 6 9,843 109,150
NET CURRENT ASSETS 40,146 22,397
TOTAL ASSETS LESS CURRENT
LIABILITIES

40,146

24,497

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 40,145 24,496
SHAREHOLDERS' FUNDS 40,146 24,497

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 23 September 2024 and were signed by:





M Garcia - Director


MYCOSY PARTNERS LTD (Registered number: SC648825)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

MYCOSY PARTNERS LTD is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. OPERATING PROFIT

The operating profit is stated after charging:

31.12.23 31.12.22
£    £   
Depreciation - owned assets 2,100 2,100

MYCOSY PARTNERS LTD (Registered number: SC648825)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023
and 31 December 2023 8,373
DEPRECIATION
At 1 January 2023 6,273
Charge for year 2,100
At 31 December 2023 8,373
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 2,100

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors - 97,411
Taxation and social security 4,163 3,367
Other creditors 5,680 8,372
9,843 109,150